Hui Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hui Zhang has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Bo Zhu
The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University
1 shared publicationDongyang Yu
The Affiliated Huai’an Hospital of Xuzhou Medical University
1 shared publication- Fang Ge
The Affiliated Huai’an Hospital of Xuzhou Medical University
1 shared publication - Genji Bai
The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University
1 shared publication Lei Han
The Affiliated Huai’an Hospital of Xuzhou Medical University
1 shared publicationQian Wang
The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University
1 shared publication
Latest Publications
- Open Access
- 1 June 2026
- Published by SAGE Publications in Technology in Cancer Research & Treatment
- Vol. 25
Longitudinal MRI Temporal Transformer Fusion Model for Predicting Induction Chemotherapy Efficacy in Locally Advanced Nasopharyngeal Carcinoma
Introduction: Induction chemotherapy (IC) represents a standard treatment approach for locally advanced nasopharyngeal carcinoma (LA-NPC), yet marked interpatient heterogeneity in treatment response persists. This study sought to develop and evaluate a temporal Transformer–based fusion model integrating baseline pretreatment and early intratreatment MRI to facilitate early risk stratification and inform individualized therapeutic management. Materials and Methods: In this retrospective multicenter study, 488 patients with pathologically confirmed LA-NPC were enrolled from two institutions. All patients underwent induction chemotherapy and received contrast-enhanced T1-weighted imaging (CE-T1WI) before treatment initiation (Pre-IC) and at an early post-treatment time point (Post-IC). A dual-branch independent network architecture with Twins-SVT as the backbone was implemented to separately extract deep learning features from Pre-IC and Post-IC CE-T1WI images. Subsequently, an attention-based temporal Transformer fusion module was designed to model nonlinear longitudinal interactions and dynamic evolutionary patterns between pre- and post-treatment tumor representations, yielding a longitudinal temporal fusion predictive model. Gradient-weighted class activation mapping (Grad-CAM) was applied to enhance interpretability through visualization of salient imaging regions. Results: The deep learning model based on Pre-IC imaging yielded an AUC of 0.844 (95% CI: 0.767–0.922) in the internal validation cohort and 0.819 (95% CI: 0.725–0.913) in the external validation cohort. The Post-IC–based model demonstrated AUCs of 0.863 (95% CI: 0.790–0.936) and 0.838 (95% CI: 0.753–0.923) in the internal and external validation cohorts, respectively. The longitudinal temporal Transformer fusion model achieved higher predictive performance, with AUCs increasing to 0.889 (95% CI: 0.824–0.955) in the internal validation cohort and 0.865 (95% CI: 0.791–0.939) in the external validation cohort. Conclusion: Compared with single–time point models, a longitudinal contrast-enhanced MRI–based temporal Transformer fusion model enabled more accurate early individualized prediction of induction chemotherapy response in patients with locally advanced nasopharyngeal carcinoma.
- 1 June 2026
- Published by SAGE Publications in Technology in Cancer Research & Treatment
- Vol. 25
Open AccessLongitudinal MRI Temporal Transformer Fusion Model for Predicting Induction Chemotherapy Efficacy in Locally Advanced Nasopharyngeal Carcinoma
Introduction: Induction chemotherapy (IC) represents a standard treatment approach for locally advanced nasopharyngeal carcinoma (LA-NPC), yet marked interpatient heterogeneity in treatment response persists. This study sought to develop and evaluate a temporal Transformer–based fusion model integrating baseline pretreatment and early intratreatment MRI to facilitate early risk stratification and inform individualized therapeutic management. Materials and Methods: In this retrospective multicenter study, 488 patients with pathologically confirmed LA-NPC were enrolled from two institutions. All patients underwent induction chemotherapy and received contrast-enhanced T1-weighted imaging (CE-T1WI) before treatment initiation (Pre-IC) and at an early post-treatment time point (Post-IC). A dual-branch independent network architecture with Twins-SVT as the backbone was implemented to separately extract deep learning features from Pre-IC and Post-IC CE-T1WI images. Subsequently, an attention-based temporal Transformer fusion module was designed to model nonlinear longitudinal interactions and dynamic evolutionary patterns between pre- and post-treatment tumor representations, yielding a longitudinal temporal fusion predictive model. Gradient-weighted class activation mapping (Grad-CAM) was applied to enhance interpretability through visualization of salient imaging regions. Results: The deep learning model based on Pre-IC imaging yielded an AUC of 0.844 (95% CI: 0.767–0.922) in the internal validation cohort and 0.819 (95% CI: 0.725–0.913) in the external validation cohort. The Post-IC–based model demonstrated AUCs of 0.863 (95% CI: 0.790–0.936) and 0.838 (95% CI: 0.753–0.923) in the internal and external validation cohorts, respectively. The longitudinal temporal Transformer fusion model achieved higher predictive performance, with AUCs increasing to 0.889 (95% CI: 0.824–0.955) in the internal validation cohort and 0.865 (95% CI: 0.791–0.939) in the external validation cohort. Conclusion: Compared with single–time point models, a longitudinal contrast-enhanced MRI–based temporal Transformer fusion model enabled more accurate early individualized prediction of induction chemotherapy response in patients with locally advanced nasopharyngeal carcinoma.
- Open Access
- 27 February 2026
- Published by SAGE Publications in Technology in Cancer Research & Treatment
- Vol. 25
Transformer-Based Deep Learning Model Using MRI-Derived Microvascular Atlas for Predicting Lymphovascular Invasion in Breast Cancer Patients
Introduction: Lymphovascular invasion (LVI), an aggressive pathological manifestation of breast cancer, is closely associated with increased risk of distant metastasis and poor prognosis. This study proposes a novel modeling strategy that integrates MRI-derived microvascular atlas parameters with the TwinsSVT deep learning architecture to enable noninvasive prediction of LVI status in breast cancer patients and to explore its biological interpretability. Materials and Methods: A total of 436 breast cancer patients from two medical centers, all pathologically confirmed postoperatively, were retrospectively enrolled. All patients underwent high-resolution multi-b-value diffusion-weighted imaging (DWI) prior to surgery. From the MRI data, four types of microvascular simulation parameter maps were reconstructed within tumor regions: apparent diffusion coefficient (ADC), mean flow velocity (v_m), velocity dispersion (v_s), and angiographic branching index (ANB), aiming to characterize intratumoral microcirculation and vascular structural complexity. These functional parametric maps were individually input into separate encoder branches of the TwinsSVT model to extract multi-scale spatial features. A multi-layer Transformer fusion module was then employed to capture structural interactions across modalities, thereby constructing a multi-parametric fusion model. Model performance was evaluated using metrics including area under the curve (AUC) and F1 score. Results: Compared with single-parameter models, the multi-parametric fusion model demonstrated significantly improved predictive performance, with AUCs of 0.881 (95% CI: 0.781-0.982) and 0.859 (95% CI: 0.764-0.953) in internal and external validation cohorts, respectively. Grad-CAM visualizations revealed that the model predominantly focused on tumor margins and regions of high vascular density, suggesting a strong correlation between the model's attention and actual pathological structures. Conclusion: The deep learning model constructed based on MRI-derived microvascular simulation atlases enables noninvasive preoperative prediction of LVI status in breast cancer patients. By effectively capturing structural information and offering biological interpretability, the model holds promise as a robust imaging-based tool for precision subtyping and clinical decision support.
- 27 February 2026
- Published by SAGE Publications in Technology in Cancer Research & Treatment
- Vol. 25
Open AccessTransformer-Based Deep Learning Model Using MRI-Derived Microvascular Atlas for Predicting Lymphovascular Invasion in Breast Cancer Patients
Introduction: Lymphovascular invasion (LVI), an aggressive pathological manifestation of breast cancer, is closely associated with increased risk of distant metastasis and poor prognosis. This study proposes a novel modeling strategy that integrates MRI-derived microvascular atlas parameters with the TwinsSVT deep learning architecture to enable noninvasive prediction of LVI status in breast cancer patients and to explore its biological interpretability. Materials and Methods: A total of 436 breast cancer patients from two medical centers, all pathologically confirmed postoperatively, were retrospectively enrolled. All patients underwent high-resolution multi-b-value diffusion-weighted imaging (DWI) prior to surgery. From the MRI data, four types of microvascular simulation parameter maps were reconstructed within tumor regions: apparent diffusion coefficient (ADC), mean flow velocity (v_m), velocity dispersion (v_s), and angiographic branching index (ANB), aiming to characterize intratumoral microcirculation and vascular structural complexity. These functional parametric maps were individually input into separate encoder branches of the TwinsSVT model to extract multi-scale spatial features. A multi-layer Transformer fusion module was then employed to capture structural interactions across modalities, thereby constructing a multi-parametric fusion model. Model performance was evaluated using metrics including area under the curve (AUC) and F1 score. Results: Compared with single-parameter models, the multi-parametric fusion model demonstrated significantly improved predictive performance, with AUCs of 0.881 (95% CI: 0.781-0.982) and 0.859 (95% CI: 0.764-0.953) in internal and external validation cohorts, respectively. Grad-CAM visualizations revealed that the model predominantly focused on tumor margins and regions of high vascular density, suggesting a strong correlation between the model's attention and actual pathological structures. Conclusion: The deep learning model constructed based on MRI-derived microvascular simulation atlases enables noninvasive preoperative prediction of LVI status in breast cancer patients. By effectively capturing structural information and offering biological interpretability, the model holds promise as a robust imaging-based tool for precision subtyping and clinical decision support.